Robert J Mentz Selected Research

Furosemide (Lasix)

10/2022	Ascertaining Death Events in a Pragmatic Clinical Trial: Insights From the TRANSFORM-HF Trial.
1/2022	An evaluation of torsemide in patients with heart failure and renal disease.
1/2021	Pragmatic Design of Randomized Clinical Trials for Heart Failure: Rationale and Design of the TRANSFORM-HF Trial.
1/2019	Death: The Simple Clinical Trial Endpoint.
2/2016	Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).
9/2015	Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial.
5/2015	Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital.
3/2015	A reappraisal of loop diuretic choice in heart failure patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert J Mentz Research Topics

Disease

184	Heart Failure 12/2022 - 01/2011
19	Type 2 Diabetes Mellitus (MODY) 01/2022 - 04/2016
18	Cardiovascular Diseases (Cardiovascular Disease) 06/2022 - 01/2014
14	Myocardial Infarction 06/2021 - 11/2012
11	Cardiomyopathies (Cardiomyopathy) 09/2022 - 08/2014
11	Stroke (Strokes) 01/2022 - 01/2014
10	Diabetes Mellitus 01/2020 - 02/2013
9	Dyspnea (Shortness of Breath) 01/2020 - 01/2015
7	Chronic Renal Insufficiency 01/2022 - 12/2012
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2014
5	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 04/2012
4	Atrial Fibrillation 01/2022 - 08/2015
4	Chronic Disease (Chronic Diseases) 01/2022 - 11/2014
4	Renal Insufficiency (Renal Failure) 01/2020 - 02/2013
4	Hypertension (High Blood Pressure) 12/2019 - 12/2012
4	Death (Near-Death Experience) 04/2019 - 07/2010
4	Cardio-Renal Syndrome 07/2016 - 07/2010
3	Peripheral Arterial Disease 10/2021 - 12/2019
3	Disease Progression 01/2021 - 03/2017
3	Weight Loss (Weight Reduction) 01/2021 - 03/2017
3	Edema (Dropsy) 01/2020 - 07/2015
2	Brain Death (Brain Dead) 01/2022 - 01/2020
2	Heart Diseases (Heart Disease) 01/2022 - 12/2015
2	Fibrosis (Cirrhosis) 01/2022 - 03/2015
2	Coronary Disease (Coronary Heart Disease) 01/2022 - 01/2017
2	Infections 10/2021 - 01/2020
2	Frailty 01/2021 - 01/2018
2	Neoplasms (Cancer) 01/2021 - 01/2020
2	Iron Deficiencies 01/2021 - 04/2019
2	Atherosclerosis 12/2019 - 01/2017
2	Ischemic Stroke 11/2019 - 01/2017
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2018 - 02/2017
2	Inflammation (Inflammations) 01/2017 - 10/2016
2	Body Weight (Weight, Body) 04/2016 - 12/2013
2	Left Ventricular Dysfunction 02/2015 - 11/2012
2	Systolic Heart Failure 09/2014 - 11/2012

Drug/Important Bio-Agent (IBA)

27	Brain Natriuretic Peptide (Natrecor)FDA Link 06/2022 - 03/2015
16	DiureticsIBA 01/2022 - 06/2012
16	Tolvaptan FDA Link 01/2018 - 11/2012
14	Vasopressins (Vasopressin)IBA 01/2018 - 11/2012
12	Biomarkers (Surrogate Marker)IBA 06/2022 - 10/2014
11	Exenatide (Byetta)FDA Link 01/2020 - 04/2016
9	Torsemide (Demadex)FDA LinkGeneric 10/2022 - 03/2015
9	sacubitril and valsartan sodium hydrate drug combinationIBA 12/2021 - 01/2017
8	Furosemide (Lasix)FDA LinkGeneric 10/2022 - 03/2015
8	pro-brain natriuretic peptide (1-76)IBA 09/2022 - 01/2018
8	Natriuretic PeptidesIBA 09/2022 - 01/2011
8	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2014
8	CreatinineIBA 01/2022 - 05/2014
8	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2019 - 06/2012
7	AlbuminsIBA 01/2022 - 02/2013
6	Glucose (Dextrose)FDA LinkGeneric 09/2022 - 10/2019
6	SodiumIBA 09/2022 - 02/2013
6	TroponinIBA 06/2022 - 12/2015
6	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 07/2012
6	Neprilysin (Neutral Endopeptidase)IBA 06/2019 - 09/2015
6	Angiotensin Receptors (Angiotensin II Receptor)IBA 06/2019 - 09/2015
5	Hemoglobins (Hemoglobin)IBA 01/2022 - 05/2014
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 07/2012
5	vericiguatIBA 01/2022 - 01/2021
5	Uric Acid (Urate)IBA 06/2021 - 12/2014
4	Troponin IIBA 06/2022 - 12/2018
4	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 12/2018
3	empagliflozinIBA 01/2022 - 01/2021
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 10/2019
3	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2021
3	Angiotensin Receptor AntagonistsIBA 01/2021 - 01/2018
3	Liraglutide FDA Link 01/2021 - 12/2018
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 12/2020 - 01/2018
3	CalciumIBA 01/2020 - 10/2013
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020 - 09/2018
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 01/2016
3	AldosteroneIBA 01/2020 - 03/2015
3	Spironolactone (Aldactone)FDA LinkGeneric 01/2020 - 01/2017
3	Glucagon-Like Peptide-1 ReceptorIBA 12/2019 - 04/2016
3	Pharmaceutical PreparationsIBA 01/2018 - 08/2014
2	dapagliflozinIBA 09/2022 - 10/2019
2	ChloridesIBA 06/2021 - 05/2021
2	BilirubinIBA 06/2021 - 05/2021
2	Hormones (Hormone)IBA 06/2021 - 05/2021
2	PotassiumIBA 01/2020 - 01/2019
2	Troponin T (Troponin T1)IBA 12/2019 - 12/2015
2	AnticoagulantsIBA 11/2019 - 10/2018
2	Oxygen (Dioxygen)IBA 12/2018 - 04/2014
2	ElectrolytesIBA 09/2015 - 09/2014
2	Antidiuretic Hormone Receptor AntagonistsIBA 01/2015 - 05/2014

Therapy/Procedure

68	Therapeutics 12/2022 - 01/2011
16	Palliative Care (Palliative Therapy) 01/2022 - 07/2010
10	Patient Readmission 01/2022 - 02/2013
7	Heart-Assist Devices 01/2022 - 05/2013
4	Heart Transplantation (Grafting, Heart) 01/2022 - 01/2020
4	Length of Stay 10/2016 - 04/2012
3	Secondary Prevention 01/2022 - 01/2017
3	Investigational Therapies (Experimental Therapy) 01/2020 - 07/2010
3	Cardiac Resynchronization Therapy 02/2019 - 02/2015
2	Transplantation 01/2022 - 01/2022
2	Surgical Amputation (Amputations) 10/2021 - 12/2019
2	Drug Therapy (Chemotherapy) 12/2020 - 09/2015
2	Glycemic Control 01/2020 - 04/2016
2	Long-Term Care 05/2011 - 07/2010